PATENT CLAIM ANALYSIS

Application Number: 16409945
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["424", "139100"]

Abstract:
The present invention relates to Tau-binding antibodies and binding fragments thereof.

Claim (Index 1):
An isolated Tau-binding antibody or binding fragment thereof, wherein said Tau-binding antibody or binding fragment thereof competes for binding to tau with a Tau-binding antibody or binding fragment comprising:\n a light chain variable region comprising SEQ ID NO: 1 (CDR1), SEQ ID NO: 2 (CDR2), and SEQ ID NO: 3 (CDR3); and a heavy chain variable region comprising SEQ ID NO: 4 (CDR1), SEQ ID NO: 5 (CDR2), and SEQ ID NO: 6 (CDR3).

Metadata:
- Claim Count in Document: 3.0
- Percentile: 100.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15742087', '15742070', '15257086', '14654176', '14532531']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7621651904795488
- 35 USC 102 Novelty (BERT): 0.6497223893367995
- Combined Prediction Score: 0.7509209103652739
- Mean Citation Score: 458.3158580000001
- Max Citation Score: 699.13245
- Similarity Product: 570.0441828058363

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test